Associate Professional Specialist, Chemical and Biomolecular Engineering
University of Notre Dame
Harnessing Nanotechnology for the Treatment of Blood Cancers.
Nanotechonology has been recognized as a paradigm changing phenomena in the treatment and diagnosis of cancers. Despite the advancements made in this field in the past decade, application of nanomedicine in blood cancers have been overlooked. Recent evidence shows that, contrary to common opinion, angiogenesis plays a significant role in numerous hematologic malignancies including multiple myeloma, providing the rationale to apply nanotechnology in the treatment of blood cancers to improve patient outcome. My research focuses applying nanotechnology to target multiple myeloma as well as its bone marrow microenvironment to overcome certain mechanisms of cell resistance.